Chroni c Lyme borreliosis (CLB) can present not only in different organs but also in different patterns . Although many theories exist about the mechanisms leading to CLB, it is known that viable Borrelia burgdorfer i can persist for decades and cause late skin manifestation s of acrodermatitis chronica atrophican s (ACA). Thus, the immunopathogeneti c findings in ACA can serve as a model for studying the chronic course of Lyme borreliosis. Recent findings indicate that the most importan t cell for antigen presentation , the epidermal Langerhan s cell (LC), is invaded by B. burgdorfer i in early Lyme borreliosis. Therefore, LCs were stained immunohistochemicall y with different markers to investigate their functional activity. Numbers of CD1a / LCs were reduced in erythema migrans but normal or slightly elevated in ACA. In both diseases there was also a marked downregulatio n of major histocompatibilit y complex class II molecules on LCs, as measured by staining of human leukocyte antigen DR. This phenomenon might be a mechanism that protects against the presentatio n of autoantigen s and may be the cause of the impaired capacity of LCs to eliminate B. burgdorfer i antigens, thus explaining why CLB is chronic.
Lyme borreliosis is a multisystem inflammatory disease persist and gradually progress into ACA over a period of months to years or can disappear. However, Borrelia organisms caused by Borrelia burgdorferi. Patients treated adequately with antibiotics in the early phase of infection show a good can survive in the skin, leading to chronic inflammation and thus causing ACA, the final stage of CLB. clinical response. However, the time of infection and mode of development of various organ manifestations often cannot be At first, the cellular immune response seen locally in erythema migrans is mainly composed of CD3 / T cells, with a followed. Moreover, it is evident that the type of Borrelia strain and the immunosusceptibility of the host influence the predominance of CD4 / helper/inducer cells, 30%-40% CD8 / cytotoxic/suppressor T cells, and numerous macrophages [8] . expansion of clinical symptoms, which may explain differences between the manifestations of chronic Lyme borreliosis (CLB)
The composition of this mononuclear infiltrate persists into the ACA stage. The percentage of CD4 / T lymphocytes, however, seen in patients in the United States and Europe. Several recent articles have described the symptoms of CLB increases up to 90% [8] [9] [10] . Although the presence of many plasma cells is histologically pathognomonic, the predomi- [1] [2] [3] [4] [5] [6] [7] . Studies of CLB in the rhesus monkey model have revealed characteristic clinical, histopathologic, and laboratory nance of CD22 / /CD20 / B cells varies [9, 10] . But what happens as a consequence of this active inflammafindings [3] .
Although not yet reported to occur in animal models, acrodermatitis chronica atrophicans (ACA) of the skin, tion? Studies of persistent erythema migrans lesions have shown that the mononuclear cellular elements cluster around caused by Borrelia afzelii, a subtype of B. burgdorferi sensu lato, develops gradually. Therefore, ACA may be a good model vessel walls. These findings, which can be compared with histologic changes in CLB as described with regard to various orfor studying the immunopathogenic events that lead to chronic disease.
gans, are suggestive of an angiopathy accompanied by lymphocytic infiltrate [3, 11] . Moreover, an interstitial myositis of the smooth arrector muscles of hair develops, and these gradually Histopathologic and Immunohistologic Findings in the become atrophic in ACA [12] . Immunohistochemical studies Skin have shown that in ACA, both the hair muscles and the muscle of vessel walls can no longer be stained with antibodies against The first stage of Lyme borreliosis, erythema migrans, is a self-limited dermatosis. Nevertheless, the erythema can either smooth muscle actin [12] . Deposition of immunocomplexes in dermal vessel walls as well as granular IgM or C3 deposits can sometimes be seen at the dermoepidermal junction [10] . The inflammatory infiltrate tinocytes show vacuolization, as also seen in lichen planus or early stage of borreliosis suggests that their function might be altered in Lyme borreliosis. graft-versus-host disease of the skin [10, 13, 14] .
The end stage of ACA is atrophy of epidermis, collagen, In a recent study, skin biopsy specimens from seven patients with erythema migrans and 19 with ACA were investigated and elastic fibers. In half of the cases, ACA is associated with neuropathy. Perineural lymphocytic infiltrates severe enough immunohistochemically for their expression of CD1a-the most reliable antibody to identify LCs [28] -human major to obliterate blood vessels, destroy myelinated fibers, and thus lead to axonal nerve degeneration are typical of this late manihistocompatibility complex (MHC) human leukocyte antigen (HLA) subregions HLA-DR, -DQ, and -DP, and several other festation [15] . different leukocyte differentiation antigens. These studies were performed in order to determine whether the number or funcImmune Response in ACA tion of epidermal LCs was altered (M. Silberer, F. Koszik, E. Aberer, manuscript in preparation). Patients with ACA mount an immune response but cannot eliminate the pathogen B. burgdorferi. In the sera of such Semiautomatic image analysis of CD1a staining revealed a decreased density of epidermal LCs in erythema migrans secpatients, high titers of IgG antibody to B. burgdorferi can still be detected years after treatment [16, 17] . Although most of tions (598 { 240 per mm 2 of epidermis), vs. a normal or even higher density in ACA sections (835 { 317/mm 2 ) (figure 1), these antibodies are of the IgG1 isotype, there is a distinct IgG2 and IgG3 component [18] . In a minority of patients, IgM as compared with their density in normal skin (460-1,000/ mm 2 [29] ). antibodies can also be detected by ELISA [16] , although these findings are mostly associated with a positive rheumatoid facMore important, MHC class II molecule expression, as evaluated by HLA-DR expression, was considerably downregutor. On the other hand, polyclonal hyperimmunoglobulinemia, mostly of the IgM isotype, is often seen in ACA [19] . lated in erythema migrans and ACA (by 28% and 18%, respectively). In contrast, CD1a and HLA-DR were equally expressed The cellular immune response of peripheral blood lymphocytes seen in CLB [20] is not regularly found in ACA. For in normal skin [29] . In addition, HLA-DP and -DQ molecules were downregulated on epidermal dendritic cells. example, in lymphocyte proliferation tests performed by Breier et al. in 19 ACA patients, only 3 patients exhibited a marked stimulation index against viable B. burgdorferi subspecies gariBacterial Elimination and Survival nii organisms, while 4 patients showed no stimulation at all [21] . In contrast, Büchner et al. reported positive lymphoRecent experiments have shed light on the elimination and survival of borreliae. On the one hand, in vitro experiments cyte transformation tests in most ACA patients when sonicated B. burgdorferi sensu stricto was used as antigen [22] . A similar have shown that borreliae are internalized by macrophages, catabolized in endosomes, loaded with MHC class II molecules, test using B. afzelii as antigen has, to the best of our knowledge, not yet been performed. Since this strain has been isolated from and then presented to CD4 / cells [30] . On the other hand, uptake of borreliae by coiling phagocytosis has also been obpatients with ACA, the highest proliferation rates could be expected if the latter strain were used as antigen.
served; the borreliae enter the cytosol and join the MHC class I pathway involving CD8 / suppressor/cytotoxic cells for lysis. Since the majority of infiltrating cells in the skin biopsies The Role of Epidermal Langerhans Cells we investigated were of the CD4 helper/inducer type and since a high number of CD68 / macrophages in those samples also Antigen-presenting cells play a central role in immune defense mechanisms. One particular type of antigen-presenting expressed HLA-DR, we think that the MHC class II pathway rather than the class I pathway is involved in immune defense cell, epidermal dendritic Langerhans cells (LCs), have been studied in several chronic infectious diseases, including syphimechanisms in ACA (Silberer M., Koszik F., Aberer E., manuscript in preparation). lis, leprosy, leishmaniasis, and HIV infection [23] [24] [25] [26] . Ultrastructural studies of skin biopsy specimens from patients with Immunohistochemical staining of ACA skin biopsy specimens with a monoclonal antibody to flagellin has shown that erythema migrans have shown that B. burgdorferi selectively invades and destroys LCs [27] .
ACA-affected skin harbors several forms of borreliae. Heavily stained, clumped, intertwined forms and granular Borrelia Moreover, recently performed in vitro studies proved that skin-and blood-derived dendritic cells are also able to effistructures among collagen fibers (figure 2) are also seen to form after incubation with antibodies to B. burgdorferi in vitro, ciently engulf B. burgdorferi (Figueira L., Nestle F., Rittig M., Groscurth P. Phagocytosis and antigen-processing of B. burgand delicate dispersed forms are found lying in degenerating collagen fibers [31] . The existence of these forms has been dorferi by human dendritic cells. Presented at the 4th International Workshop on Langerhans Cells [Venice] . October 1996, confirmed ultrastructurally [27] . Previous studies have shown that ACA can be successfully p. 132). Although intracellular survival of B. burgdorferi in LCs has not yet been described, the parasitism of LCs in the treated with oral antibiotics given for 30 days [19] ; the skin lesions regress slowly over the next 6-12 months. Repeated of oral antibiotics, no Borrelia DNA fragments could be detected in the urine after 6 months, and all patients were free biopsies of ACA-affected skin from two patients treated with ceftriaxone for 15 days showed that one patient still had periof further clinical symptoms at 12 months. In still other studies, PCR analysis of biopsy specimens of previous skin lesions at vascular lymphoplasmocytic infiltrates 1 year later, although no Borrelia DNA could be detected in the urine with a nested a median of 1.5 years after treatment showed no sign of Borrelia DNA [32] . PCR method and flagellin primers [19] .
In patients treated orally for only 20 days or intravenously Yet, the question still remains: where do Borrelia organisms survive in patients with CLB? An inadequate immune response for 15 days, either skin involvement or associated symptoms persisted. In 10 patients with ACA treated with a 30-day course and an evasion of bacteria into immunologically privileged / cells leads to a reduction immunohistochemical studies using the flagellar H9724 monoclonal antibody, some macrophages stained positively for borof both arthritis and spirochete number. Treatment with recombinant IL-4 augments resistance to B. burgdorferi in normal reliae, not only in skin biopsy specimens from patients with ACA but also in control biopsy specimens from healthy indisusceptible mice as well as mice with severe combined immunodeficiency [49] . This resistance is also accompanied by a viduals [31] . These findings were interpreted as being due to cross-reactive epitopes of the monoclonal flagellar antibody significant reduction in IFN-g response of spleen cells and decreased serum levels of IgG2a and IgG3a antibodies. Since and several human tissue components [41] . In other experiments, immunization of C3H/HeNcr mice with B. burgdorferi has been shown to result in Th1 cell prolifin CLB. Intracellular survival of B. burgdorferi in antigenpresenting cells, although not yet described as occurring in eration, a strong delayed-type hypersensitivity reaction, and an IgG2 response [51] . However, the small amounts of IgG1 Lyme borreliosis, can be possible only when antigens are not presented appropriately. Besides macrophages and B-lymphoantibodies produced in these immunized animals favored also the participation of Th2 cells, which allow the survival of cytes, dendritic cells, especially LCs, are capable of functioning as antigen-presenting cells and thus are responsible for the bacteria. Ultraviolet B radiation prior to immunization suppressed this induction of primary antigen-specific immune reactions [42] [43] [44] . Later on, other professional and nonprofessional antidelayed-type hypersensitivity response by a mechanism involving IL-10 [51] . Injection of mouse antibody to IL-10 abrogated gen-presenting cells are able to stimulate T lymphocytes.
Parasitism of LCs has been described in association with the effect of ultraviolet B radiation. This ultraviolet irradiation of LCs in vitro altered their antigen-presenting capability in several infectious diseases, such as leprosy, leishmaniasis, and AIDS [24, 42, 45] . For example, in leprosy, dermal macrophages that such cells failed to stimulate Th1 clones but preserved the ability to activate Th2 clones. From former studies it is known and LCs are infected with Mycobacterium leprae [24] . These parasitized cells then express weaker MHC class II molecules that ultraviolet B irradiation of BALB/c mice reduces significantly the number of epidermal LCs, whereas the average denthan do uninfected cells. In addition, the vast majority of epidermal LCs, although not infected and evenly distributed, do not sity of MHC class II molecules on the remaining cells is not reduced [52] . Therefore, it was assumed that Th1 cells might stain with HLA-DR molecules [24] . In lepromatous leprosy, in which macrophages are not able to kill M. leprae, there is a lack require a higher density of MHC class II-associated antigen for their activation than would Th2 cells. of T cell-derived lymphokines such as IFN-g and IL-2 [46] . In fact, injected IL-2 can modify the immune response in leprosy
In further experiments it was suggested that this ultraviolet irradiation-induced immunomodulation was mediated by cothrough a cell-mediated pathway that results in a reduced bacterial load and a T-helper type 1 (Th1) cell response. After IL-2 stimulatory signals, such as IL-1, that can convert LCs from immunogenic to tolerogenic antigen-presenting cells [53] . Borreliae may induce the release of factors or cytokines such as IL-10 that can inhibit the expression of HLA-DR molecules Therefore, the possibility exists that IL-1, which is induced by B. burgdorferi [54] [55] . In vitro investigations have shown that MHC class II response, traces of MHC class II molecules seem to be sufficient for T cell activation. Thus, even minimal HLA-DR molemolecules are downregulated on antigen-presenting cells after coculture with Th cell clones in the presence of antigenic pepcules, as expressed on LCs in ACA, are sufficient for establishment of a cellular and humoral immune response. tides of tetanus toxoid or staphylococcal superantigen, which elicit a strong HLA-DR-restricted T cell response.
In leprosy, cross-reactivity between M. leprae antigens and human tissues is suspected to be the cause of chronic disease Several hypotheses were suggested as the cause of this downregulation. (1) Downregulation occurs when antigenic peptides [60] . Similarly, in CLB, molecular mimicry is suspected to lead to several manifestations of disease [40, 61] . In both diseases, catabolized in macrophages are recognized by CD4
/ helper T cells, in order to control the size of a T cell clone and provide downregulation of MHC class II molecules on LCs has been observed. Graft-versus-host-like changes seen in ACAa homeostatic mechanism [55] . (2) Downregulation occurs for completion of T-B cell collaboration after antigen presentation, affected skin do not rule out local autoimmune reactions. Thus, to prevent manifest autoimmune disease, immunolimiting excessive T cell help to the triggered B cells, or (3) it occurs for focusing the T cell response to one or a few tolerance that includes tolerance of B. burgdorferi might be sustained in ACA. Factors that abolish the downregulation of immunodominant peptides.
(4) LCs of patients with AIDS express decreased amounts MHC class II molecules might be of importance in new therapeutic strategies against CLB to eliminate the microorganism. of MHC class II molecules. Polyclonal B-cell activation, as seen in these patients and in patients with ACA, could cause the appearance of autoantibodies or immunocomplexes that
